A Phase III, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Efficacy and Safety Trial of Bapineuzumab (AAB-001, ELN115727) in Patients with Mild to Moderate Alzheimer's Disease

Study Status: 
Study Description: 

Please click on the study title and see the attached memo.

Study Coordinator(s): 

Martha van der Vliet

Gad Marshall

Telephone:  617-732-8085

301-302 summary for internal use.doc39 KB